Precipio ROE 2010-2024 | PRPO
Current and historical return on equity (ROE) values for Precipio (PRPO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Precipio ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-09-30 |
$-0.00B |
$0.01B |
-23.53% |
| 2024-06-30 |
$-0.00B |
$0.01B |
-23.08% |
| 2024-03-31 |
$-0.00B |
$0.01B |
-29.63% |
| 2023-12-31 |
$-0.01B |
$0.01B |
-36.36% |
| 2023-09-30 |
$-0.01B |
$0.01B |
-56.14% |
| 2023-06-30 |
$-0.01B |
$0.01B |
-64.52% |
| 2023-03-31 |
$-0.01B |
$0.01B |
-57.97% |
| 2022-12-31 |
$-0.01B |
$0.02B |
-62.34% |
| 2022-09-30 |
$-0.01B |
$0.02B |
-55.81% |
| 2022-06-30 |
$-0.01B |
$0.02B |
-46.81% |
| 2022-03-31 |
$-0.01B |
$0.02B |
-48.00% |
| 2021-12-31 |
$-0.01B |
$0.03B |
-34.41% |
| 2021-09-30 |
$-0.01B |
$0.03B |
-39.02% |
| 2021-06-30 |
$-0.01B |
$0.03B |
-51.43% |
| 2021-03-31 |
$-0.01B |
$0.02B |
-57.14% |
| 2020-12-31 |
$-0.01B |
$0.01B |
-107.69% |
| 2020-09-30 |
$-0.02B |
$0.01B |
-125.49% |
| 2020-06-30 |
$-0.02B |
$0.01B |
-115.38% |
| 2020-03-31 |
$-0.02B |
$0.01B |
-143.40% |
| 2019-12-31 |
$-0.01B |
$0.01B |
-107.69% |
| 2019-09-30 |
$-0.02B |
$0.02B |
-151.11% |
| 2019-06-30 |
$-0.02B |
$0.01B |
-194.87% |
| 2019-03-31 |
$-0.02B |
$0.01B |
-172.97% |
| 2018-12-31 |
$-0.02B |
$0.01B |
-200.00% |
| 2018-09-30 |
$-0.03B |
$0.01B |
-221.28% |
| 2018-06-30 |
$-0.03B |
$0.01B |
-220.69% |
| 2018-03-31 |
$-0.04B |
$0.01B |
-230.30% |
| 2017-12-31 |
$-0.03B |
$0.01B |
-412.50% |
| 2017-09-30 |
$-0.02B |
$0.02B |
-584.62% |
| 2017-06-30 |
$-0.01B |
$0.02B |
144.00% |
| 2017-03-31 |
$0.00B |
$-0.02B |
0.00% |
| 2016-12-31 |
$-0.00B |
$-0.01B |
21.82% |
| 2016-09-30 |
$-0.02B |
$-0.02B |
154.84% |
| 2016-06-30 |
$-0.03B |
$-0.02B |
345.95% |
| 2016-03-31 |
$-0.04B |
$-0.02B |
1400.00% |
| 2015-12-31 |
$-0.03B |
$-0.01B |
-906.67% |
| 2015-09-30 |
$-0.02B |
$0.01B |
-228.57% |
| 2015-06-30 |
$-0.01B |
$0.01B |
-126.32% |
| 2015-03-31 |
$-0.01B |
$0.01B |
-140.54% |
| 2014-12-31 |
$-0.01B |
$0.01B |
-136.59% |
| 2014-09-30 |
$-0.01B |
$0.01B |
-106.67% |
| 2014-06-30 |
$-0.02B |
$0.01B |
-144.00% |
| 2014-03-31 |
$-0.02B |
$0.01B |
-111.48% |
| 2013-12-31 |
$-0.02B |
$0.01B |
-95.77% |
| 2013-09-30 |
$-0.02B |
$0.02B |
-75.00% |
| 2013-06-30 |
$-0.01B |
$0.02B |
-54.55% |
| 2013-03-31 |
$-0.01B |
$0.02B |
-43.48% |
| 2012-12-31 |
$-0.01B |
$0.02B |
-38.30% |
| 2012-09-30 |
$-0.01B |
$0.02B |
-32.94% |
| 2012-06-30 |
$-0.01B |
$0.03B |
-40.00% |
| 2012-03-31 |
$-0.01B |
$0.03B |
-125.71% |
| 2011-12-31 |
$-0.01B |
$0.01B |
-293.33% |
| 2011-09-30 |
$-0.01B |
$-0.00B |
-369.23% |
| 2011-06-30 |
$-0.01B |
$0.00B |
-183.33% |
| 2011-03-31 |
$-0.01B |
$0.01B |
-70.59% |
| 2010-12-31 |
$-0.00B |
$0.01B |
-30.77% |
| 2010-09-30 |
$-0.00B |
$0.01B |
-19.05% |
| 2010-06-30 |
$-0.00B |
$0.01B |
-9.09% |
| 2010-03-31 |
$-0.00B |
$0.01B |
-8.70% |
| 2009-12-31 |
$-0.00B |
$0.01B |
-17.02% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.014B |
$0.015B |
|
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
|
